Area of research
Rheumatology · Hematology
Research interest
Research interests include Autoimmune and Inflammatory Disorders Research, Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, and Inflammatory Myopathies and Dermatomyositis.
Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses
Relationship between epa level of supervision with their associated subcompetency milestone levels in pediatric fellow assessment
Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis
Intravenous administration of anakinra in children with macrophage activation syndrome
International Consensus for the Dosing of Corticosteroids in <scp>Childhood‐Onset</scp> Systemic Lupus Erythematosus With Proliferative Lupus Nephritis
Giant Coronary Aneurysms in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection
Risk factors associated with <i>Pneumocystis jirovecii</i> pneumonia in juvenile myositis in North America
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy
Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study
Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease
Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis
Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
Creating the Subspecialty Pediatrics Investigator Network
Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis
Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults
Using the Effects of Youngsters’ Eyesight on Quality of Life Questionnaire to Measure Visual Outcomes in Children With Uveitis
The Association of Race With Childhood Uveitis
Risk Markers of Juvenile Idiopathic Arthritis-associated Uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
Pilot Study of Etanercept in Patients With Refractory Juvenile Dermatomyositis
Meta-analysis confirms association between TNFA- G238A variant and JIA, and between PTPN22-C1858T variant and oligoarticular, RF-polyarticular and RF-positive polyarticular JIA